28386663|t|A child with phenylketonuria and focal segmental glomerulosclerosis, the bright side of proteinuria
28386663|a|Phenylketonuria (PKU) is the most common inborn error of amino acid metabolism. Phenylalanine hydroxylase is the underlying deficient enzyme. If left untreated, growth failure, microcephaly, global developmental delay, seizures and severe intellectual impairment would characterize the clinical picture of PKU. On the other side of protein homeostasis lies nephrotic syndrome. It is a well-known quantitative defect due to significant proteinuria. Focal segmental glomerulosclerosis (FSGS) is a special congenital variant affecting children and adults. Hereby, we describe a three- year old male child who presented with generalized edema and global developmental delay. Investigations revealed PKU along with FSGS. We assume that congenital nephrosis ameliorated the picture of PKU, and had a salutary effect on the growth and development. Such coexistence between PKU and FSGS hasn't been described before.
28386663	2	7	child	T100	C0008059
28386663	13	28	phenylketonuria	T047	C0031485
28386663	33	67	focal segmental glomerulosclerosis	T047	C0333497
28386663	88	99	proteinuria	T033	C0033687
28386663	100	115	Phenylketonuria	T047	C0031485
28386663	117	120	PKU	T047	C0031485
28386663	134	140	common	T081	C0205214
28386663	141	178	inborn error of amino acid metabolism	T047	C0002514
28386663	180	205	Phenylalanine hydroxylase	T116,T126	C0031456
28386663	224	233	deficient	T169	C0011155
28386663	234	240	enzyme	T116,T126	C0014442
28386663	250	259	untreated	T033	C0332155
28386663	261	275	growth failure	T047	C0878787
28386663	277	289	microcephaly	T019	C0025958
28386663	291	317	global developmental delay	T048	C0557874
28386663	319	327	seizures	T184	C0036572
28386663	332	362	severe intellectual impairment	T048	C4294877
28386663	369	381	characterize	T052	C1880022
28386663	386	402	clinical picture	T201	C0683325
28386663	406	409	PKU	T047	C0031485
28386663	432	439	protein	T116,T123	C0033684
28386663	440	451	homeostasis	T038	C0019868
28386663	457	475	nephrotic syndrome	T047	C0027726
28386663	496	508	quantitative	T081	C0392762
28386663	509	515	defect	T169	C1457869
28386663	523	534	significant	T078	C0750502
28386663	535	546	proteinuria	T033	C0033687
28386663	548	582	Focal segmental glomerulosclerosis	T047	C0333497
28386663	584	588	FSGS	T047	C0333497
28386663	595	602	special	T080	C0205555
28386663	603	613	congenital	T080	C1744681
28386663	614	621	variant	T080	C0205419
28386663	622	631	affecting	T169	C0392760
28386663	632	640	children	T100	C0008059
28386663	645	651	adults	T100	C0001675
28386663	691	695	male	T032	C0086582
28386663	696	701	child	T100	C0008059
28386663	706	715	presented	T033	C0150312
28386663	721	738	generalized edema	T033	C1850534
28386663	743	769	global developmental delay	T048	C0557874
28386663	771	785	Investigations	T058	C1261322
28386663	786	794	revealed	T080	C0443289
28386663	795	798	PKU	T047	C0031485
28386663	810	814	FSGS	T047	C0333497
28386663	831	851	congenital nephrosis	T047	C3501848
28386663	852	863	ameliorated	T033	C0184511
28386663	879	882	PKU	T047	C0031485
28386663	894	909	salutary effect	T080	C0205556
28386663	917	939	growth and development	T040	C0018271
28386663	966	969	PKU	T047	C0031485
28386663	974	978	FSGS	T047	C0333497